نتائج البحث - "Second Primary"

81

Second primary gastric cancers in a region with an overall high risk of gastric cancer

المؤلفون: Maria José Bento, Nuno Lunet, Samantha Morais, Luís Antunes

المساهمون: Instituto de Saúde Pública da Universidade do Porto

المصدر: Gaceta Sanitaria v.34 n.4 2020
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)
Gaceta Sanitaria, Vol 34, Iss 4, Pp 393-398 (2020)
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
Universitat Politècnica de Catalunya (UPC)

مصطلحات موضوعية: Male, medicine.medical_specialty, Neoplasias gástricas, Epidemiology, Population, Stomach neoplasms, Rectum, Second primary neoplasms, Gastroenterology, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Neoplasias primarias secundarias, Risk Factors, Stomach Neoplasms, Internal medicine, medicine, Epidemiología, Humans, Cumulative incidence, 030212 general & internal medicine, Survivors, Registries, education, education.field_of_study, business.industry, 030503 health policy & services, Incidence (epidemiology), lcsh:Public aspects of medicine, Incidence, Public Health, Environmental and Occupational Health, Cancer, lcsh:RA1-1270, Neoplasms, Second Primary, Second primary cancer, medicine.disease, Primary cancer, digestive system diseases, medicine.anatomical_structure, Cohort, Sistema de registros, Female, 0305 other medical science, business

وصف الملف: application/pdf; text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2077cef0e95938605284a9572b3ee116Test
https://hdl.handle.net/10216/143177Test

82

Second primary malignancy in myelofibrosis patients treated with ruxolitinib

المؤلفون: Elena Maria Elli, Florian H. Heidel, Uros Markovic, Fabrizio Pane, Gianpietro Semenzato, Daniela Bartoletti, Francesca Palandri, Giulia Benevolo, Mauro Krampera, Malgorzata Monika Trawinska, Micaela Bergamaschi, Mario Tiribelli, Giovanni Caocci, Lucia Catani, Elisabetta Abruzzese, Massimo Breccia, Rossella Stella, Antonio Cuneo, Fabio D'Amore, Alessandro Isidori, Costanza Bosi, Monica Crugnola, Lisa Gandolfi, Domenico Russo, Alessandra Iurlo, Nicola Polverelli, Roberto M. Lemoli, Michele Cavo, Gianni Binotto, Roberto Latagliata, Francesco Cavazzini, Bruno Martino, Daniele Cattaneo, Nicola Vianelli, Novella Pugliese, Luigi Scaffidi, Massimiliano Bonifacio, Mariella D'Adda, Alessia Tieghi, Giuseppe Auteri, Giuseppe A. Palumbo

المساهمون: Polverelli N., Elli E.M., Abruzzese E., Palumbo G.A., Benevolo G., Tiribelli M., Bonifacio M., Tieghi A., Caocci G., D'Adda M., Bergamaschi M., Binotto G., Heidel F.H., Cavazzini F., Crugnola M., Pugliese N., Bosi C., Isidori A., Bartoletti D., Auteri G., Latagliata R., Gandolfi L., Martino B., Scaffidi L., Cattaneo D., D'Amore F., Trawinska M.M., Stella R., Markovic U., Catani L., Pane F., Cuneo A., Krampera M., Semenzato G., Lemoli R.M., Vianelli N., Breccia M., Russo D., Cavo M., Iurlo A., Palandri F.

مصطلحات موضوعية: Male, Ruxolitinib, Skin Neoplasms, Lymphoma, ruxolitinib, Aggressive lymphoma, Gastroenterology, Hydroxycarbamide, 0302 clinical medicine, myelofibrosi, Risk Factors, Neoplasms, 80 and over, Aged, 80 and over, Thrombocytosis, Incidence (epidemiology), Incidence, Hazard ratio, Neoplasms, Second Primary, Hematology, Arteries, Middle Aged, Second Primary, JAK inhibitor, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, medicine.medical_specialty, Context (language use), myelofibrosis, JAK inhibitors, second cancer, toxicity, NO, 03 medical and health sciences, Internal medicine, Nitriles, medicine, Humans, Janus Kinase Inhibitors, Myelofibrosis, Aged, Retrospective Studies, business.industry, Thrombosis, medicine.disease, Case-Control Studies, Follow-Up Studies, Multivariate Analysis, Primary Myelofibrosis, Pyrazoles, Pyrimidines, business, 030215 immunology

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8abbcaca804c8d9620fa8227a1112fTest
http://hdl.handle.net/11562/1033116Test

83

Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents

المساهمون: University of Rome TorVergata, European Society for Blood and Marrow Transplantation (EBMT), Service d’Hématologie [Institut Paoli Calmettes, Marseille], Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Department of Clinical Haematology, Nottingham University Hospitals—City Campus, Dept. of Hematology, University hospitals, Department of Haematology, Charles University Hospital, University Hospital Brno, Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw - Poland, Department of Hematology, University Hospital Lund, Trinity College Dublin, Department I of Internal Medicine, University of Cologne, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Lille Inflammation Research International Center - U 995 (LIRIC), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Queen's University [Belfast] (QUB), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), University Hospital Hamburg-Eppendorf, Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), National Institute for Health Research

المصدر: Biology of Blood and Marrow Transplantation, 24, 930-936
Biology of Blood and Marrow Transplantation, 24, 5, pp. 930-936
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (5), pp.930-936. ⟨10.1016/j.bbmt.2018.01.006⟩

مصطلحات موضوعية: Male, Oncology, Benzylamines, [SDV]Life Sciences [q-bio], Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], medicine.medical_treatment, Hematopoietic stem cell transplantation, Cyclams, 0302 clinical medicine, Heterocyclic Compounds, Cumulative incidence, Prospective Studies, Prospective cohort study, Multiple myeloma, Incidence, Incidence (epidemiology), Age Factors, Hematopoietic Stem Cell Transplantation, Neoplasms, Second Primary, Hematology, Middle Aged, second primary malignancies, Hematopoietic Stem Cell Mobilization, 3. Good health, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, medicine.drug, Adult, medicine.medical_specialty, Immunology, proteasome inhibitors, Transplantation, Autologous, Settore MED/01 - Statistica Medica, Young Adult, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, immunomodulatory drugs, Internal medicine, medicine, Humans, Autologous transplantation, Aged, Transplantation, business.industry, Plerixafor, fungi, plerixafor, 1103 Clinical Sciences, medicine.disease, business, 030215 immunology